Table 4.
Biomarkers statistically significantly associated with severe dengue (WHO 2009 classification), but only reported in a single study.
| Study | Biomarker(s) | No. of participants |
|---|---|---|
| Mapalagamage, 201827 | Nitric oxide, nitrite | 94 |
| Hapugaswatta, 202118 | Nitric oxide synthase, oxLDL, salivary oxLDL | 127 |
| Vuong, 202141 | Soluble CD163, triggering receptor expressed on myeloid cells 1 (TREM1) | 837 |
| Zain, 201746 | Fas-ligand | 42 |
| Pang, 201631 | Plasminogen activator urokinase receptor (PLAUR) | 80 |
| Nhi, 201630 | Angiotensinogen, angiotensinogen, RIMS-binding protein 3A, WD repeat domain phosphoinositide-interacting protein, titin, ceruloplasmin, serotransferrin, zinc finger FYVE domain-containing protein 26, prothrombin nesprin-2, nesprin-2, serine palmitoyltransferase 3, nuclear pore membrane glycoprotein 210, olfactory receptor 51G2, otopetrin-3, transforming growth factor-beta-induced protein ig-h3, arf-GAP with Rho-GAP domain ANK repeat and PH domain-containing protein 3, vacuolar protein sorting-associated protein 13D, alpha-2-HS-glycoprotein, antithrombin III | 50 |
| Silva, 202135 | Urinary leukotriene E4 (LTE4) | 120 |